IL-20 Is regulated by hypoxia-inducible factor and up-regulated after experimental ischemic stroke

Journal of Immunology

Volumn 182, Issue 8, 2009, Pages 5003-5012

  Chen, Wei Yu ^a   Chang, Ming Shi ^a  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; COBALT CHLORIDE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 20; INTERLEUKIN 20 ANTIBODY; INTERLEUKIN 20 RECEPTOR 1; INTERLEUKIN 20 RECEPTOR 2; INTERLEUKIN 22 RECEPTOR 1; INTERLEUKIN 8; INTERLEUKIN RECEPTOR; JANUS KINASE 2; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MONOCYTE CHEMOTACTIC PROTEIN 1; STAT3 PROTEIN; UNCLASSIFIED DRUG; COBALT; HYPOXIA INDUCIBLE FACTOR 1; INTERLEUKIN DERIVATIVE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARTILAGE CELL; CELL PROLIFERATION; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; GLIOBLASTOMA; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MALE; MONOCYTE; NONHUMAN; PRIORITY JOURNAL; RAT; UPREGULATION; ANIMAL; ANOXIA; BRAIN ISCHEMIA; CELL LINE; CHEMICALLY INDUCED DISORDER; DRUG ANTAGONISM; GENETICS; METABOLISM; PATHOLOGY; PROMOTER REGION; SPRAGUE DAWLEY RAT; STROKE;

ANIMALS; ANOXIA; BRAIN ISCHEMIA; CELL LINE; COBALT; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1; INTERLEUKINS; MALE; PROMOTER REGIONS, GENETIC; RATS; RATS, SPRAGUE-DAWLEY; STROKE; UP-REGULATION;

EID: 65249129300     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0803653     Document Type: Article

References (54)

1. Wang, Q., X. N. Tang, and M. A. Yenari. 2007. The inflammatory response in stroke. J. Neuroimmunol. 184: 53-68.
2. Muir, K. W., P. Tyrrell, N. Sattar, and E. Warburton. 2007. Inflammation and ischaemic stroke. Curr. Opin. Neurol. 20: 334-342.
3. Sharp, F. R., A. Lu, Y. Tang, and D. E. Millhorn. 2000. Multiple molecular penumbras after focal cerebral ischemia. J. Cereb. Blood Flow Metab. 20: 1011-1032. (Pubitemid 30445613)
4. Dirnagl, U., C. Iadecola, and M. A. Moskowitz. 1999. Pathobiology of ischaemic stroke: an integrated view. Trends Neurosci. 22: 391-397. (Pubitemid 29453643)
5. Fawcett, J. W., and R. A. Asher. 1999. The glial scar and central nervous system repair. Brain Res. Bull. 49: 377-391. (Pubitemid 29385505)
6. Barone, F. C., and G. Z. Feuerstein. 1999. Inflammatory mediators and stroke: new opportunities for novel therapeutics. J. Cereb. Blood Flow Metab. 19: 819-834. (Pubitemid 30173383)
7. Chamorro, A., and J. Hallenbeck. 2006. The harms and benefits of inflammatory and immune responses in vascular disease. Stroke 37: 291-293. (Pubitemid 43731945)
8. Samson, Y., B. Lapergue, and H. Hosseini. 2005. Inflammation and ischaemic stroke: current status and future perspectives. Rev. Neurol. 161: 1177-1182. (Pubitemid 43116619)
9. Benveniste, E. N. 1998. Cytokine actions in the central nervous system. Cytokine Growth Factor Rev. 9: 259-275. (Pubitemid 29019710)
10. Buttini, M., A. Sauter, and H. W. Boddeke. 1994. Induction of interleukin-1β mRNA after focal cerebral ischaemia in the rat. Brain Res. Mol. Brain Res. 23: 126-134. (Pubitemid 24090989)
11. Yamasaki, Y., N. Matsuura, H. Shozuhara, H. Onodera, Y. Itoyama, and K. Kogure. 1995. Interleukin-1 as a pathogenetic mediator of ischemic brain damage in rats. Stroke 26: 676-680, discussion 681.
12. Liu, T., R. K. Clark, P. C. McDonnell, P. R. Young, R. F. White, F. C. Barone, and G. Z. Feuerstein. 1994. Tumor necrosis factor-α expression in ischemic neurons. Stroke 25: 1481-1488. (Pubitemid 24198599)
13. Sairanen, T., O. Carpen, M. L. Karjalainen-Lindsberg, A. Paetau, U. Turpeinen, M. Kaste, and P. J. Lindsberg. 2001. Evolution of cerebral tumor necrosis factor-α production during human ischemic stroke. Stroke 32: 1750-1758. (Pubitemid 32772202)
14. Garau, A., R. Bertini, F. Colotta, F. Casilli, P. Bigini, A. Cagnotto, T. Mennini, P. Ghezzi, and P. Villa. 2005. Neuroprotection with the CXCL8 inhibitor repertaxin in transient brain ischemia. Cytokine 30: 125-131. (Pubitemid 40501727)
15. Chen, Y., J. M. Hallenbeck, C. Ruetzler, D. Bol, K. Thomas, N. E. Berman, and S. N. Vogel. 2003. Overexpression of monocyte chemoattractant protein 1 in the brain exacerbates ischemic brain injury and is associated with recruitment of inflammatory cells. J. Cereb. Blood Flow Metab. 23: 748-755. (Pubitemid 36713680)
16. Pang, L., W. Ye, X. M. Che, B. J. Roessler, A. L. Betz, and G. Y. Yang. 2001. Reduction of inflammatory response in the mouse brain with adenoviral-mediated transforming growth factor-ss1 expression. Stroke 32: 544-552. (Pubitemid 32155249)
17. Ooboshi, H., S. Ibayashi, T. Shichita, Y. Kumai, J. Takada, T. Ago, S. Arakawa, H. Sugimori, M. Kamouchi, T. Kitazono, and M. Iida. 2005. Postischemic gene transfer of interleukin-10 protects against both focal and global brain ischemia. Circulation 111: 913-919. (Pubitemid 40279894)
18. Blumberg, H., D. Conklin, W. F. Xu, A. Grossmann, T. Brender, S. Carollo, M. Eagan, D. Foster, B. A. Haldeman, A. Hammond, et al. 2001. Interleukin 20: discovery, receptor identification, and role in epidermal function. Cell 104: 9-19. (Pubitemid 32144968)
19. Pestka, S., C. D. Krause, D. Sarkar, M. R. Walter, Y. Shi, and P. B. Fisher. 2004. Interleukin-10 and related cytokines and receptors. Annu. Rev. Immunol. 22: 929-979.
20. Dumoutier, L., C. Leemans, D. Lejeune, S. V. Kotenko, and J. C. Renauld. 2001. Cutting edge: STAT activation by IL-19, IL-20 and mda-7 through IL-20 receptor complexes of two types. J. Immunol. 167: 3545-3549. (Pubitemid 32910793)
21. Wei, C. C., Y. H. Hsu, H. H. Li, Y. C. Wang, M. Y. Hsieh, W. Y. Chen, C. H. Hsing, and M. S. Chang. 2006. IL-20: biological functions and clinical implications. J. Biomed. Sci. 13: 601-612.
22. Sa, S. M., P. A. Valdez, J. Wu, K. Jung, F. Zhong, L. Hall, I. Kasman, J. Winer, Z. Modrusan, D. M. Danilenko, and W. Ouyang. 2007. The effects of IL-20 subfamily cytokines on reconstituted human epidermis suggest potential roles in cutaneous innate defense and pathogenic adaptive immunity in psoriasis. J. Immunol. 178: 2229-2240.
23. Wei, C. C., W. Y. Chen, Y. C. Wang, P. J. Chen, J. Y. Lee, T. W. Wong, W. C. Chen, J. C. Wu, G. Y. Chen, M. S. Chang, and Y. C. Lin. 2005. Detection of IL-20 and its receptors on psoriatic skin. Clin. Immunol. 117: 65-72. (Pubitemid 41725471)
24. Hsu, Y. H., H. H. Li, M. Y. Hsieh, M. F. Liu, K. Y. Huang, L. S. Chin, P. C. Chen, H. H. Cheng, and M. S. Chang. 2006. Function of interleukin-20 as a proinflammatory molecule in rheumatoid and experimental arthritis. Arthritis Rheum. 54: 2722-2733.
25. Caligiuri, G., S. V. Kaveri, and A. Nicoletti. 2006. IL-20 and atherosclerosis: another brick in the wall. Arterioscler. Thromb. Vasc. Biol. 26: 1929-1930. (Pubitemid 44253771)
26. Chen, W. Y., B. C. Cheng, M. J. Jiang, M. Y. Hsieh, and M. S. Chang. 2006. IL-20 is expressed in atherosclerosis plaques and promotes atherosclerosis in apolipoprotein E-deficient mice. Arterioscler. Thromb. Vasc. Biol. 26: 2090-2095. (Pubitemid 44253793)
27. Li, H. H., Y. H. Hsu, C. C. Wei, P. T. Lee, W. C. Chen, and M. S. Chang. 2008. Interleukin-20 induced cell death in renal epithelial cells and was associated with acute renal failure. Genes Immun. 9: 395-404.
28. Heuze-Vourc'h, N., M. Liu, H. Dalwadi, F. E. Baratelli, L. Zhu, L. Goodglick, M. Pold, S. Sharma, R. D. Ramirez, J. W. Shay, et al. 2005. IL-20, an antiangiogenic cytokine that inhibits COX-2 expression. Biochem. Biophys. Res. Commun. 333: 470-475.
29. Hsieh, M. Y., W. Y. Chen, M. J. Jiang, B. C. Cheng, T. Y. Huang, and M. S. Chang. 2006. Interleukin-20 promotes angiogenesis in a direct and indirect manner. Genes Immun. 7: 234-242.
30. Tritsaris, K., M. Myren, S. B. Ditlev, M. V. Hubschmann, I. van der Blom, A. J. Hansen, U. B. Olsen, R. Cao, J. Zhang, T. Jia, et al. 2007. IL-20 is an arteriogenic cytokine that remodels collateral networks and improves functions of ischemic hind limbs. Proc. Natl. Acad. Sci. USA 104: 15364-15369. (Pubitemid 47502923)
31. Mabjeesh, N. J., D. Escuin, T. M. LaVallee, V. S. Pribluda, G. M. Swartz, M. S. Johnson, M. T. Willard, H. Zhong, J. W. Simons, and P. Giannakakou. 2003. 2ME2 inhibits tumor growth and angiogenesis by disrupting microtubules and dysregulating HIF. Cancer Cell 3: 363-375.
32. Endres, M., Z. Q. Wang, S. Namura, C. Waeber, and M. A. Moskowitz. 1997. Ischemic brain injury is mediated by the activation of poly(ADP-ribose) polymerase. J. Cereb. Blood Flow Metab. 17: 1143-1151. (Pubitemid 27514738)
33. Chen, W. Y., Y. T. Cheng, H. Y. Lei, C. P. Chang, C. W. Wang, and M. S. Chang. 2005. IL-24 inhibits the growth of hepatoma cells in vivo. Genes Immun. 6: 493-499. (Pubitemid 43090507)
34. Yuan, Y., G. Hilliard, T. Ferguson, and D. E. Millhorn. 2003. Cobalt inhibits the interaction between hypoxia-inducible factor-α and von Hippel-Lindau protein by direct binding to hypoxia-inducible factor-α. J. Biol. Chem. 278: 15911-15916. (Pubitemid 36799707)
35. 2 homeostasis by hypoxiainducible factor 1. Annu. Rev. Cell Dev. Biol. 15: 551-578.
36. Silver, J., and J. H. Miller. 2004. Regeneration beyond the glial scar. Nat. Rev. Neurosci. 5: 146-156.
37. Chen, C., Q. Hu, J. Yan, J. Lei, L. Qin, X. Shi, L. Luan, L. Yang, K. Wang, J. Han, et al. 2007. Multiple effects of 2ME2 and D609 on the cortical expression of HIF-1α and apoptotic genes in a middle cerebral artery occlusion-induced focal ischemia rat model. J. Neurochem. 102: 1831-1841. (Pubitemid 47329256)
38. Bergeron, M., A. Y. Yu, K. E. Solway, G. L. Semenza, and F. R. Sharp. 1999. Induction of hypoxia-inducible factor-1 (HIF-1) and its target genes following focal ischaemia in rat brain. Eur. J. Neurosci. 11: 4159-4170. (Pubitemid 30009246)
39. Chavez, J. C., F. Agani, P. Pichiule, and J. C. LaManna. 2000. Expression of hypoxia-inducible factor-1α in the brain of rats during chronic hypoxia. J. Appl. Physiol. 89: 1937-1942.
40. Chavez, J. C., and J. C. LaManna. 2002. Activation of hypoxia-inducible factor-1 in the rat cerebral cortex after transient global ischemia: potential role of insulin-like growth factor-1. J. Neurosci. 22: 8922-8931.
41. Vangeison, G., D. Carr, H. J. Federoff, and D. A. Rempe. 2008. The good, the bad, and the cell type-specific roles of hypoxia inducible factor-1α in neurons and astrocytes. J. Neurosci. 28: 1988-1993. (Pubitemid 351302661)
42. Rudge, J. S., and J. Silver. 1990. Inhibition of neurite outgrowth on astroglial scars in vitro. J. Neurosci. 10: 3594-3603.
43. Li, L., A. Lundkvist, D. Andersson, U. Wilhelmsson, N. Nagai, A. C. Pardo, C. Nodin, A. Stahlberg, K. Aprico, K. Larsson, et al. 2008. Protective role of reactive astrocytes in brain ischemia. J. Cereb. Blood Flow Metab. 28: 468-481. (Pubitemid 351304260)
44. Faulkner, J. R., J. E. Herrmann, M. J. Woo, K. E. Tansey, N. B. Doan, and M. V. Sofroniew. 2004. Reactive astrocytes protect tissue and preserve function after spinal cord injury. J. Neurosci. 24: 2143-2155.
45. Hosoi, T., S. Wada, S. Suzuki, Y. Okuma, S. Akira, T. Matsuda, and Y. Nomura. 2004. Bacterial endotoxin induces IL-20 expression in the glial cells. Brain Res. Mol. Brain Res. 130: 23-29. (Pubitemid 39440733)
46. Cheung, W. M., C. K. Wang, J. S. Kuo, and T. N. Lin. 1999. Changes in the level of glial fibrillary acidic protein (GFAP) after mild and severe focal cerebral ischemia. Chin. J. Physiol. 42: 227-235.
47. Witt, K. A., K. S. Mark, S. Hom, and T. P. Davis. 2003. Effects of hypoxia-reoxygenation on rat blood-brain barrier permeability and tight junctional protein expression. Am. J. Physiol. 285: H2820-H2831.
48. Offner, H., S. Subramanian, S. M. Parker, M. E. Afentoulis, A. A. Vandenbark, and P. D. Hurn. 2006. Experimental stroke induces massive, rapid activation of the peripheral immune system. J. Cereb. Blood Flow Metab. 26: 654-665.
49. Otkjaer, K., K. Kragballe, C. Johansen, A. T. Funding, H. Just, U. B. Jensen, L. G. Sorensen, P. L. Norby, J. T. Clausen, and L. Iversen. 2007. IL-20 gene expression is induced by IL-1β through mitogen-activated protein kinase and NF-κB-dependent mechanisms. J. Invest. Dermatol. 127: 1326-1336. (Pubitemid 46762975)
50. Herrmann, O., B. Baumann, R. de Lorenzi, S. Muhammad, W. Zhang, J. Kleesiek, M. Malfertheiner, M. Kohrmann, I. Potrovita, I. Maegele, et al. 2005. IKK mediates ischemia-induced neuronal death. Nat. Med. 11: 1322-1329. (Pubitemid 41752913)
51. Davies, C. A., S. A. Loddick, S. Toulmond, R. P. Stroemer, J. Hunt, and N. J. Rothwell. 1999. The progression and topographic distribution of interleukin-1β expression after permanent middle cerebral artery occlusion in the rat. J. Cereb. Blood Flow Metab. 19: 87-98. (Pubitemid 29283584)
52. Vila, N., J. Castillo, A. Davalos, and A. Chamorro. 2000. Proinflammatory cytokines and early neurological worsening in ischemic stroke. Stroke 31: 2325-2329.
53. Dimitrijevic, O. B., S. M. Stamatovic, R. F. Keep, and A. V. Andjelkovic. 2007. Absence of the chemokine receptor CCR2 protects against cerebral ischemia/reperfusion injury in mice. Stroke 38: 1345-1353.
54. Huang, K. Y., R. M. Lin, W. Y. Chen, C. L. Lee, Y. J. J., and M. S. Chang. 2008. IL-20 may contribute to the pathogenesis of human intervertebral disc herniation. Spine 33: 2034-2040.